Retrograde Open Mesenteric Stenting for Acute and Chronic Mesenteric Ischaemia: Results from an Intestinal Stroke Centre.
Acute Disease
/ mortality
Aged
Chronic Disease
/ mortality
Endovascular Procedures
/ adverse effects
Feasibility Studies
Female
Hospital Mortality
Humans
Intraoperative Complications
/ epidemiology
Male
Mesenteric Arteries
/ diagnostic imaging
Mesenteric Ischemia
/ diagnosis
Mesenteric Vascular Occlusion
/ diagnosis
Middle Aged
Postoperative Complications
/ epidemiology
Reoperation
/ statistics & numerical data
Retrospective Studies
Stents
/ adverse effects
Treatment Outcome
Complications
Covered stent-grafts
Mesenteric ischaemia
Retrograde open mesenteric stenting
Superior mesenteric artery
Journal
European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery
ISSN: 1532-2165
Titre abrégé: Eur J Vasc Endovasc Surg
Pays: England
ID NLM: 9512728
Informations de publication
Date de publication:
Jul 2021
Jul 2021
Historique:
received:
12
08
2020
revised:
09
03
2021
accepted:
21
03
2021
pubmed:
10
5
2021
medline:
21
8
2021
entrez:
9
5
2021
Statut:
ppublish
Résumé
To report the intra-operative adverse events (IOAEs) and the initial and one year outcomes of retrograde open mesenteric stenting (ROMS) using balloon expandable covered stents for acute and chronic mesenteric ischaemia. Clinical data and outcomes of all consecutive patients treated with ROMS for acute and chronic mesenteric ischaemia at an intestinal stroke centre between November 2012 and September 2019 were reviewed. ROMS was performed using balloon expandable covered stents. Endpoints included IOAEs, in hospital mortality, post-operative complications, and re-interventions. One year overall survival, freedom from re-intervention, primary patency and assisted primary patency rates were analysed using the Kaplan-Meier time to event method. During the study period, 379 patients were referred to the centre for acute or chronic mesenteric ischaemia. Thirty-seven patients who underwent the ROMS procedure were included. All the patients had severe atherosclerotic mesenteric lesions. The ROMS technical success rate was 89% in this cohort. The rate of IOAEs was 19% and included four cases of retrograde recanalisation failure. All ROMS failures occurred in patients presenting with flush superior mesenteric artery occlusion and they were treated by mesenteric bypass. Ten patients (27%) underwent bowel resection, four of which resulted in a short bowel syndrome (11%). The in hospital mortality rate was 27%. Post-operative complications and re-intervention rates were 67% (n = 25) and 32% (n = 12), respectively. The median follow up was 20.2 months (interquartile range 29). The estimated one year overall survival for the cohort was 70.1% (95% confidence interval [CI] 52.5% - 82.2%). The estimated freedom from re-intervention at one year was 61.1% (95% CI 42.3 - 75.4). The one year primary patency and assisted primary patency rates were 84.54% (95% CI 63.34 - 94) and 92.4% (95% CI 72.8 - 98), respectively. ROMS procedures offer acceptable one year outcomes for mesenteric ischaemia but are associated with frequent stent related complications. Precise pre-operative planning, high quality imaging, and meticulous stent placement techniques may limit the occurrence of such events.
Identifiants
pubmed: 33965329
pii: S1078-5884(21)00276-8
doi: 10.1016/j.ejvs.2021.03.019
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
55-63Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2021 European Society for Vascular Surgery. Published by Elsevier B.V. All rights reserved.